MDLN Medline Inc.

NAS · US · Healthcare · Medical Instruments & Supplies · medline.com

35.80USD+0.53%Mkt Cap: 48.17B $P/E: 89.501d ago

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through tw…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$143.60BUSDP/E 46.6

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$26.51BUSDP/E 48.2

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation

$14.98BUSDP/E 10.8

BAX

Baxter International Inc.

$12.52BUSD

COO

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Bausch + Lomb Corporation

$6.13BUSD

Key Statistics

Company

Market Cap48.17B USD

Enterprise Value48.69B USD

Revenue (TTM)29.94B USD

Gross Profit7.52B USD

Net Income (TTM)1.16B USD

Revenue/Share34.14 USD

Last Price35.80 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees45.0K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)89.50

P/E (Forward)22.58

PEG—

EV/EBITDA19.34

EV/Revenue1.63

P/S1.60

P/B2.70

EPS (TTM)0.40

EPS (Forward)1.58

52W Range

31.4922% of range50.88

52W High50.88 USD

52W Low31.49 USD

Profitability

Gross Margin26.44%

Oper. Margin0.82%

EBITDA Margin8.41%

Profit Margin4.08%

ROE10.79%

ROA3.01%

Growth

Revenue Growth11.60%

Earnings Growth262.00%

Cash Flow & Leverage

Operating CF1.74B USD

CapEx (TTM)447.00M USD

FCF Margin2.84%

FCF Yield1.77%

Net Debt9.94B USD

Net Debt/EBITDA3.95

Balance Sheet

Debt/Equity1.18

Current Ratio4.33

Quick Ratio2.45

Book Value/Sh13.20 USD

Cash/Share3.08 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.6 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)44.54 USD

Upside (mean)+24.4%

Target Range34.00 USD – 55.00 USD

34.00+24.4% to mean55.00

# Analysts26

Ownership

Shares Out.877.35M

Float341.00M

Insiders0.26%

Institutions115.42%

Short Interest

Short Ratio6.3d

Short % Float9.81%

Short % Out.4.71%

Shares Short41.31M

Short (prev mo.)36.17M

Technical

SMA 5035.33 (+1.3%)

SMA 20040.33 (-11.2%)

Beta—

S&P 52W Chg14.58%

Avg Vol (30d)8.57M

Avg Vol (10d)10.11M

Technical Indicators

RSI (14)58.0

MACD0.1114

MACD Signal-0.2541

MACD Hist.+0.3655

BB Upper36.52 USD

BB Middle33.81 USD

BB Lower31.10 USD

BB Width16.03%

ATR (14)1.249 USD

Vol Ratio (20d)1.07x